| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5581755 | Clinical Lymphoma Myeloma and Leukemia | 2016 | 33 Pages |
Abstract
NK cell counts after allo-HSCT, especially on day 30, were predictive of acute graft-versus-host disease, nonrelapse mortality, and survival. Serial lymphocyte subset analysis can be used to identify and treat patients at risk during the early period after allo-HSCT.
Related Topics
Health Sciences
Medicine and Dentistry
Anesthesiology and Pain Medicine
Authors
Seo Yeon Kim, Hyewon Lee, Mi-Soon Han, Hyoeun Shim, Hyeon-Seok Eom, Boram Park, Sun-Young Kong,